Eslicarbazepine Acetate Chiral Peak Id Mixuture

Product Description
CAT No.
ALN-E034012
CAS No.
NA
Mol. F.
C15H12N2O2 : 2(C17H16N2O3)
Mol. Wt.
845
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 10-oxo-10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide with (S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate with(R)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate
Smiles : O=C(C1=CC=CC=C1N2C(N)=O)CC3=C2C=CC=C3.NC(N4C5=C(C[C@H](OC(C)=O)C6=CC=CC=C64)C=CC=C5)=O.NC(N7C8=CC=CC=C8[C@H](OC(C)=O)CC9=C7C=CC=C9)=O
Inchi : InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1/i12D2,14D2
Technical Data
Reference
Stability indicating hplc method for the determination of eslicarbazepine acetate and its impurities in bulk drugs and pharmaceutical dosage forms
Mudigonda Srinivas,1,2 Narasimha Rao Avupati,1 Shakil Sait,1 and K. MukkantinJournal of Liquid Chromatography & Related Technologies, 35:1550u20131564, 2012
Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma
Gilberto Alves,1 Isabel Figueiredo,1 Margarida Castel-Branco,1 Ana Loureiro,2 Ana Fortuna,1 Amílcar Falcão1
Stability indicating thin-layer chromatographic determination of eslicarbazepine acetate as bulk drug: Application to forced degradation study
and Margarida Caramona – Biomedical chromatography Biomed. Chromatogr. 21: 1127–1134 (2007)
RFQ